Sisram Medical Ltd (HKG:1696)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.290
+0.100 (2.39%)
Mar 12, 2025, 4:08 PM HKT
8.88%
Market Cap 1.96B
Revenue (ttm) 2.78B
Net Income (ttm) 183.90M
Shares Out 468.34M
EPS (ttm) 0.39
PE Ratio 10.66
Forward PE 7.93
Dividend 0.16 (3.78%)
Ex-Dividend Date Aug 26, 2024
Volume 1,078,400
Average Volume 1,349,697
Open 4.210
Previous Close 4.190
Day's Range 4.190 - 4.360
52-Week Range 2.750 - 4.950
Beta 1.37
RSI 62.83
Earnings Date Mar 19, 2025

About Sisram Medical

Sisram Medical Ltd engages in the research, design, development, manufacture, and sales of medical aesthetics and dental equipment, home use devices, injectables, and cosmeceuticals products in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio for various wellness businesses, including hair removal, skin rejuvenation, acne and acne scars, body and face contouring, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodelling injectab... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2013
Employees 1,079
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1696
Full Company Profile

Financial Performance

In 2023, Sisram Medical's revenue was $359.29 million, an increase of 1.36% compared to the previous year's $354.48 million. Earnings were $31.50 million, a decrease of -21.59%.

Financial numbers in USD Financial Statements

News

Sirsram Medical announces NMPA approval for DAXXIFY®

Marking the introduction of the world's first and only peptide-powered botulinum toxin product to Mainland China HONG KONG , Sept. 9, 2024 /PRNewswire/ -- Sisram Medical (1696.HK), a global leading in...

6 months ago - Benzinga